Solid lipid nanoparticles containing copaiba oil and allantoin: Development and role of nanoencapsulation on the antifungal activity

Pharmazie

Volumn 70, Issue 3, 2015, Pages 155-164

  Svetlichny, G ^a   Kulkamp Guerreiro, I C ^b   Cunha, S L ^b   Silva, F E K ^b   Bueno, K ^b   Pohlmann, A R ^b   Fuentefria, A M ^b   Guterres, S S ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; ALLICIN; ANIDULAFUNGIN; COPAIBA OIL; FLUCONAZOLE; KETOCONAZOLE; OIL; SOLID LIPID NANOPARTICLE; TERBINAFINE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; LIPID; NANOPARTICLE; VEGETABLE OIL;

ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTHRODERMA OTAE; ARTICLE; BROTH DILUTION; CANDIDA PARAPSILOSIS; DERMATOPHYTE; DRUG DELIVERY SYSTEM; DYNAMIC LIGHT SCATTERING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LASER DIFFRACTION; LIGHT SCATTERING; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE LIGHT SCATTERING; NANOENCAPSULATION; NANOPARTICLE TRACKING ANALYSIS; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PICHIA KUDRIAVZEVII; TRICHOPHYTON RUBRUM; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; FABACEAE; FLOW KINETICS; FUNGUS; MEDICINAL CHEMISTRY; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ALLANTOIN; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; FABACEAE; FUNGI; LIPIDS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; PLANT OILS; RHEOLOGY;

EID: 84930251067     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2015.4116     Document Type: Article

References (60)

1. Aala F, Yusuf UK, Jamal F, Khodavandi A (2010) In vitro antifungal activity of allicin alone and in combination with two medications against Trichophyton rubrum. World J Microbiol Biotechnol 26: 2193-2198.
2. Araujo J, Nikolic S, Egea MA, Eliana B, Souto EB, Garcia ML (2011) Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surfaces: Biointerfaces 88: 150-157.
3. Araujo LU, Grabe-Guimaraes A, Mosqueira VCF, Carneiro CM, Silva-Barcellos NM (2010) Profile of wound healing process induced by allantoin. Acta Cirurgica Brasileira 25: 460-466.
4. Basile AC, Sertie JAA, Freitas PCD, Zanini AC (1988) Anti-inflammatory activity of oleoresin from Brazilian copaifera. J Ethnopharmacol 22: 101-109.
5. Bird RB, Stewart WE, Lightfoot EN (1960) Transport Phenomena. John Wiley, New York 920.
6. Bunjes H, Koch MH, Westesen K (2003) Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci 92: 1509-1520.
7. Carvalho JCT, Cascon V, Possebon LS, Morimoto MSS, Cardoso LGV, Kaplan MAC, Gilbert B (2005) Topical antiinflammatory and analgesic activities of Copaifera duckei dwyer. Phytother Res 19: 946-950.
8. Celia C, Trapassob E, Coscoa D, Paolinoc D, Fresta M (2009) Turbiscan Lab Expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surfaces B: Biointerfaces 72: 155-160.
9. Clinical laboratory standards institute (CLSI) (2008): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard-Second Edition. CLSI document M38-A2. Wayne: Clinical Laboratory Standards Institute.
10. Clinical laboratory standards institute (CLSI) (2012): Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement, CLSI document M27-S4. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
11. Da Silva AC, Sales NDP, De Araujo AV, Caldeira CF (2009) In vitro effect of plant compounds on the fungus Colletotrichum gloeosporioides Penz. isolated from passion fruit. Ciencia Agrotecnol 33: 1853-1860.
12. Dos Santos AO, Ueda-Nakamura T, Filho BPD, Junior VFV, Pinto AC, Nakamura CV (2008) Antimicrobial activity of Brazilian copaiba oils obtained from different species of the Copaifera genus. Memorias do Instituto Oswaldo Cruz, Rio de Janeiro 103: 277-281.
13. Dos Santos AO, Costa MA, Ueda-Nakamura T, Filho BPD, Junior VFV, Lima MMS, Nakamura CV (2011) Leishmania amazonensis: Effects of oral treatment with copaiba oil in mice. Exper Parasitol 129: 145-151.
14. Fava LW, Serpa PBS, Kulkamp-Guerreiro IC, Pinto AT (2013) Evaluation of viscosity and particle size distribution of fresh, chilled and frozen milk of Lacaune ewes. Small Ruminant Res 113: 247-250.
15. Gaumet M, Vargas A, Gurny R, Delie F (2008) Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69: 1-9.
16. Haghi G, Arshi R, Safaei A (2008) Improved high-performance liquid chromatography (HPLC) method for qualitative and quantitative analysis of allantoin in Zea mays. J Agricult Food Chem 56: 1205-1209.
17. Hong Z, Jun T, Yuechen Z, Xiaoquan B, Jingsi Z, Yehong M, Youwei W (2011) In vitro and in vivo activities of essential oil from the seed of Anethum graveolens L. against Candida spp. Evid-Based Complement Altern Med 2011: 659704.
18. Huang ZR, Hua SC, Yang YL, Fang JY (2008) Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin 29: 1094-1102.
19. Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Release 127: 97-109.
20. Kholodenko AL, Douglas JF (1995) Generalized Stokes-Einstein equation for spherical particle suspensions. Physical Review 51: 1081-1090.
21. KontoyiannisDP, LewisRE(2002) Antifungal drug resistance of pathogenic fungi. Lancet 359: 1135-1144.
22. Kulkamp IC, Paese K, Guterres SS, Pohlmann AR (2009) Stabilization of lipoic acid by encapsulation in polymeric nanocapsules planned for dermal application. Quimica Nova 32: 2078-2084.
23. Kulkamp-Guerreiro IC, Terroso TF, Assumpcao ER, Berlitz SJ, Contri RV, Pohlmann AR, Guterres SS (2012) Development and stability of innovative semisolid formulations containing nanoencapsulated lipoic acid for topical use. J Nanosci Nanotechnol 12: 1-10.
24. Lieberman JA, Rieger MM, Banker GS (1996) In: Rheological and Mechanical Properties of Dispersed Systems in Pharmaceutical Dosage Forms. Disperse Systems 1, 2nd ed., Radebaugh, New York, p. 552.
25. Lima SR, JuniorVF, Christo HB, PintoAC, FernandesPD(2003) In vivo and in vitro studies on the anticancer activity of Copaifera multijuga Hayne and its fractions. Phytother Res 17: 1048-1053.
26. Maciel HPF, Gouvêa CMCP, Toyama M, Smolka M, Marangoni S, PastoreGM( 2007) Extraction, purification and biochemical characterization of a peroxidase from Copaifera langsdorffii leaves. Quimica Nova 30: 1067-1071.
27. Maistro EL, Carvalho JCT, Cascon V, Kaplan MAC (2005) In vivo evaluation of the mutagenic potential and phytochemical characterization of oleoresin from Copaifera duckei Dwyer. Genet Mol Biol 28: 833-838.
28. Marcos-Arias C, Eraso E, Madariaga L, Carrillo-Munoz AJ, Quindos G (2012) In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis. Mycopathologia 173: 35-46.
29. Mazzafera P, Goncalves KV, ShimizuMM(2008) Control of allantoin accumulation in comfrey. Nat Prod Comm 3: 1411-1422.
30. McCarthy OJ (2011) Rheology of liquid and semi-solid milk products. In: Fuquay JW, Fox PF, Mcsweeney PLH. (ed) Encyclopedia of Dairy, Sciences 4, 2nd ed., Elsevier, London, p. 520-531.
31. Mota CRA, Miranda KC, Lemos JA, Costa CR, Hasimoto e Souza LK, Passos XS, Meneses e Silva H, Silva MRR (2009) Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods. Revista da Sociedade Brasileira de Medicina Tropical 42: 250-254.
32. Mendonca DE, Onofre SB (2009) Antimicrobial activity of the oil-resin produced by copaiba Copaifera multijuga Hayne (Leguminosae). Braz J Pharmacogn 19: 577-581.
33. Mengual O, Meunier G, Cayre I, Puech K, Snabre P (1999) TURBISCAN MA 2000: multiple light scattering measurements for concentrated emulsion and suspension instability analysis. Talanta 50: 445-456.
34. Moddaresi M, Brown MB, Zhao Y, Tamburic S, Jones SA (2010) The role of vehicle-nanoparticle interactions in topical drug delivery. Int J Pharm 400: 176-182.
35. Monod M (2008) Secreted proteases from dermatophytes. Mycopathologia 166: 285-294.
36. Muangman P, Aramwit P, Palapinyo S, Opasanon S, Chuangsuwanich A (2011) Efficacy of the combination of herbal extracts and a silicone derivative in the treatment of hypertrophic scar formation after burn injury. Afr J Pharm Pharmacol 5: 442-446.
37. Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA (2003) Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47: 82-86.
38. Muller RH, Mader K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 50: 161-177.
39. Paiva LAF, Cunha KMA, Santos FA, Gramosa NV, Silveira ER, Rao VSN (2002) Investigation on the wound healing activity of oleo-resin from Copaifera langsdorffii in rats. Phytother Res 16: 737-739.
40. Park BJ, Taguchi H, Kamei K, Matsuzawa T, Hyon SH, Park JC (2011) In vitro antifungal activity of epigallocatechin 3-O-gallate against clinical isolates of Dermatophytes. Yonsei Med J 52: 535-538.
41. Peres NTA, Maranhao FCA, Rossi A, Martinez-RossiNM(2010) Dermatophytes: host-pathogen interaction and antifungal resistance. Anais Brasil Dermatol 85: 657-667.
42. Perrot S, Dutertre-Catella H, Martin C, Warnet J-M, Rat P (2003) A new nondestructive cytometric assay based on resazurin metabolism and an organ culture model for the assessment of corneal viability. Cytometry Part A 55A: 7-14.
43. Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42: 4419-4431.
44. Pieri FA, Jose RM, Galvao NN, Nero LA, Scatamburlo Moreira MA (2010) Antimicrobial activity of autoclaved and non-autoclaved copaiba oil on Listeria monocytogenes. Ciência Rural, Santa Maria 40: 1797-1801.
45. Prucek R, Tucek J, Kilianova M, Panacek A, Kvitek L, Filip J, Kolar M, Tomankova K, Zboril R (2011) The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. Biomaterials 32: 4704-4713.
46. Qian C, McClements DJ (2011) Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: Factors affecting particle size. Food Hydrocolloids 25:1000-1008.
47. Qin L, Rutian L, Zhenshu Z, Xiaoping Q, Wenxian G, Lixia Y, Mi Y, Xiqun J, Baorui L (2012) Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Int J Pharm 430: 350-358.
48. Sagrera G, Bertucci A, Vazquez A, Seoane G (2011) Synthesis and antifungal activities of natural and synthetic bioflavonoids. Bioorg Med Chem 19: 3060-3073.
49. Schaffazick SR, Guterres SS (2003) Caracterizacao e Estabilidade Fisico-Quimica de Sistemas Polimericos Nanoparticulados para Administracao de Farmacos. Quimica Nova 26: 726-737.
50. Singh SB, Li X, Chen T (2011) Biotransformation of antifungal ilicicolin H. Tetrahedron Lett 52: 6190-6191.
51. Sokovic M, Van Griensven LJLD (2006) Antimicrobial activity of essential oils and their components against the three major pathogens of the cultivated button mushroom, Agaricusbisporus. Eur J Plant Pathol 116: 211-224.
52. Sznitowska M, Janicki S, BaczekA(2001) Studies on the effect of pH on the lipoidal route of penetration across stratum corneum. J Control Release 76: 327-335.
53. Thune P, Nilsen T, Hanstad I.K, Gustavsen T, Lovig Dahl H (1988) The water barrier function of the skin in relation to water content of stratum corneum, pH and skin lipids, Acta Derm.-Venereol 68: 277-283.
54. Vasconcelos KRF, Da Veiga Junior VF, Rocha WC, Bandeira MFCL (2008) In vitro assessment of antibacterial activity of a dental cement constituted of a Copaifera multijuga Hayne oil-resin. Braz J Pharmacogn 18: 733-738.
55. Veiga Junior VF, Rosas EC, Carvalho MV, Henriques MGMO, Pinto AC (2007) Chemical composition and anti-inflammatory activity of copaiba oils from Copaifera cearensis Huber ex Ducke, Copaifera reticulata Ducke and Copaifera multijuga Hayne-A comparative study. J Ethnopharmacol 112: 248-254.
56. Veraldi S, Menter A, Innocenti M (2008) Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. J Eur Acad Dermatol Venerol 22: 290-296.
57. Vermount S, Tabart J, Baldo A, Mathy A, Losson B, Mignon B (2008) Pathogenesis of dermatophytosis. Mycopathologia 166: 267-275.
58. Ying S, Chunyang L (2012) Correlation between phospholipase of Candida albicans and resistance to fluconazole. Mycoses 55: 50-55.
59. Zhao Z, Wang Q, Wang K, Brian K, Liu C, Gu Y (2010) Study of the antifungal activity of Bacillus vallismortis ZZ185 in vitro and identification of its antifungal components. Biores Technol 101: 292-297.
60. Zidan AS, Rahman Z, Khan MA (2011) Product and process understanding of a novel pediatric anti-HIV tenofovir niosomes with a high-pressure homogenizer. Eur J Pharm Sci 44: 93-102.